- data: '{"ATC编码": "C08CA01", "DSCN医院编码": "H14010016", "剂型": "片剂", "包装单位":
    "盒", "医院名称": "山西省心血管疾病医院", "医院编码": 30081, "商品名": "络活喜", "城市": "太原市",
    "季度": 3, "定义市场": "OLM", "年": 2019, "数据来源": "CPA", "数量": 2000, "最小制剂单位数量":
    14000, "最小包装数量": 7, "月": 9, "生产厂家": "辉瑞制药有限公司", "省份": "山西省", "级别":
    "三级", "给药途径": "OR", "规格": "5mg", "通用名": "氨氯地平", "金额": 59760, "集团名称":
    "辉瑞集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-12月(CPT&CPA) OLM Family_20城市_final.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "OLM Family data"}'
- data: '{"ATC编码": "C08CA05", "DSCN医院编码": "H14010016", "剂型": "控释片", "包装单位":
    "盒", "医院名称": "山西省心血管疾病医院", "医院编码": 30081, "商品名": "拜新同", "城市": "太原市",
    "季度": 3, "定义市场": "OLM", "年": 2019, "数据来源": "CPA", "数量": 2700, "最小制剂单位数量":
    18900, "最小包装数量": 7, "月": 9, "生产厂家": "Bayer Health Care AG", "省份": "山西省",
    "级别": "三级", "给药途径": "OR", "规格": "30mg", "通用名": "硝苯地平", "金额":
    72900, "集团名称": "拜耳-先灵集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-12月(CPT&CPA) OLM Family_20城市_final.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "OLM Family data"}'
- data: '{"ATC编码": "", "DSCN医院编码": "H11000255", "剂型": "其他OR", "包装单位":
    "", "医院名称": "中国医学科学院北京协和医院", "医院编码": 1100001, "商品名": "其他ARB单方药合计",
    "城市": "北京市", "季度": 1, "定义市场": "OLM", "年": 2020, "数据来源": "CPT",
    "数量": 5950, "最小制剂单位数量": 57400, "最小包装数量": "", "月": 1, "生产厂家": "", "省份":
    "北京市", "级别": "三级", "给药途径": "OR", "规格": "", "通用名": "其他ARB单方药合计",
    "金额": 43453, "集团名称": "", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2020年1-2月(CPA&CPT) OLM Family_35城市.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "OLM Family data"}'
- data: '{"ATC编码": "", "DSCN医院编码": "H11000255", "剂型": "其他OR", "包装单位":
    "", "医院名称": "中国医学科学院北京协和医院", "医院编码": 1100001, "商品名": "其他ARB复方药合计",
    "城市": "北京市", "季度": 1, "定义市场": "OLM", "年": 2020, "数据来源": "CPT",
    "数量": 1380, "最小制剂单位数量": 19600, "最小包装数量": "", "月": 1, "生产厂家": "", "省份":
    "北京市", "级别": "三级", "给药途径": "OR", "规格": "", "通用名": "其他ARB复方药合计",
    "金额": 118300, "集团名称": "", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2020年1-2月(CPA&CPT) OLM Family_35城市.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "OLM Family data"}'
- data: '{"ATC编码": "C08CA01", "DSCN医院编码": "H11000213", "剂型": "片剂", "包装单位":
    "盒", "医院名称": "卫生部北京医院", "医院编码": 1100002, "商品名": "络活喜", "城市": "北京市",
    "季度": 1, "定义市场": "OLM", "年": 2019, "数据来源": "CPT", "数量": 24050, "最小制剂单位数量":
    168350, "最小包装数量": 7, "月": 1, "生产厂家": "辉瑞制药有限公司", "省份": "北京市", "级别":
    "三级", "给药途径": "OR", "规格": "5mg", "通用名": "氨氯地平", "金额": 718614,
    "集团名称": "辉瑞集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-9月(CPT&CPA) OLM Family_20城市.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "OLM Family data"}'
- data: '{"ATC编码": "C08CA05", "DSCN医院编码": "H11000213", "剂型": "控释片", "包装单位":
    "盒", "医院名称": "卫生部北京医院", "医院编码": 1100002, "商品名": "拜新同", "城市": "北京市",
    "季度": 1, "定义市场": "OLM", "年": 2019, "数据来源": "CPT", "数量": 13010, "最小制剂单位数量":
    91070, "最小包装数量": 7, "月": 1, "生产厂家": "Bayer Health Care AG", "省份": "北京市",
    "级别": "三级", "给药途径": "OR", "规格": "30mg", "通用名": "硝苯地平", "金额":
    351270, "集团名称": "拜耳-先灵集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-9月(CPT&CPA) OLM Family_20城市.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "OLM Family data"}'
- data: '{"ATC编码": "", "DSCN医院编码": "H11000256", "剂型": "其他OR", "包装单位":
    "", "医院名称": "中国医学科学院附属肿瘤医院", "医院编码": 1100011, "商品名": "其他口服抗凝药合计", "城市":
    "北京市", "季度": 1, "定义市场": "LIX", "年": 2020, "数据来源": "CPT", "数量":
    16, "最小制剂单位数量": 224, "最小包装数量": "", "月": 1, "生产厂家": "", "省份": "北京市",
    "级别": "三级", "给药途径": "OR", "规格": "", "通用名": "其他口服抗凝药合计", "金额":
    6480, "集团名称": "", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2020年1-2月(CPA&CPT) LIX_35城市.xlsx", "providers":
    ["Sankyo", "GYC&CPA"], "sheetName": "LIX data"}'
- data: '{"ATC编码": "", "DSCN医院编码": "H11000163", "剂型": "其他OR", "包装单位":
    "", "医院名称": "北京市中医医院", "医院编码": 1100063, "商品名": "其他华法林药合计", "城市":
    "北京市", "季度": 1, "定义市场": "LIX", "年": 2020, "数据来源": "CPT", "数量":
    50, "最小制剂单位数量": 4000, "最小包装数量": "", "月": 1, "生产厂家": "", "省份": "北京市",
    "级别": "三级", "给药途径": "OR", "规格": "", "通用名": "华法林", "金额": 2000,
    "集团名称": "", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2020年1-2月(CPA&CPT) LIX_35城市.xlsx", "providers":
    ["Sankyo", "GYC&CPA"], "sheetName": "LIX data"}'
- data: '{"ATC编码": "J01MA12", "DSCN医院编码": "H11000213", "剂型": "注射剂", "包装单位":
    "盒", "医院名称": "卫生部北京医院", "医院编码": 1100002, "商品名": "可乐必妥针剂", "城市":
    "北京市", "季度": 1, "定义市场": "CV IV", "年": 2019, "数据来源": "CPT", "数量":
    1070, "最小制剂单位数量": 1070, "最小包装数量": 1, "月": 1, "生产厂家": "第一三共制药(北京)有限公司",
    "省份": "北京市", "级别": "三级", "给药途径": "IJ", "规格": "100ml∶左氧氟沙星500mg与氯化钠0.9g",
    "通用名": "左氧氟沙星", "金额": 109589.4, "集团名称": "第一三共", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-9月(CPT&CPA) CV IV_20城市.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "CV IV data"}'
- data: '{"ATC编码": "J01MA14", "DSCN医院编码": "H11000213", "剂型": "注射剂", "包装单位":
    "盒", "医院名称": "卫生部北京医院", "医院编码": 1100002, "商品名": "拜复乐针剂", "城市": "北京市",
    "季度": 1, "定义市场": "CV IV", "年": 2019, "数据来源": "CPT", "数量": 2880,
    "最小制剂单位数量": 2880, "最小包装数量": 1, "月": 1, "生产厂家": "Bayer Health Care AG",
    "省份": "北京市", "级别": "三级", "给药途径": "IJ", "规格": "250ml∶莫西沙星0.4g与氯化钠2.0g",
    "通用名": "莫西沙星", "金额": 631209.6, "集团名称": "拜耳-先灵集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-9月(CPT&CPA) CV IV_20城市.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "CV IV data"}'
- data: '{"ATC编码": "J01MA14", "DSCN医院编码": "H14010016", "剂型": "注射剂", "包装单位":
    "盒", "医院名称": "山西省心血管疾病医院", "医院编码": 30081, "商品名": "拜复乐针剂", "城市":
    "太原市", "季度": 3, "定义市场": "CV IV", "年": 2019, "数据来源": "CPA", "数量":
    80, "最小制剂单位数量": 80, "最小包装数量": 1, "月": 9, "生产厂家": "Bayer Health Care AG",
    "省份": "山西省", "级别": "三级", "给药途径": "IJ", "规格": "250ml∶莫西沙星0.4g与氯化钠2.0g",
    "通用名": "莫西沙星", "金额": 17534, "集团名称": "拜耳-先灵集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-12月(CPT&CPA) CV IV_20城市_final.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "CV IV data"}'
- data: '{"ATC编码": "J01MA14", "DSCN医院编码": "H14010083", "剂型": "注射剂", "包装单位":
    "盒", "医院名称": "太原市第三人民医院太原市传染病医院", "医院编码": 30111, "商品名": "拜复乐针剂", "城市":
    "太原市", "季度": 3, "定义市场": "CV IV", "年": 2019, "数据来源": "CPA", "数量":
    20, "最小制剂单位数量": 20, "最小包装数量": 1, "月": 9, "生产厂家": "Bayer Health Care AG",
    "省份": "山西省", "级别": "三级", "给药途径": "IJ", "规格": "250ml∶莫西沙星0.4g与氯化钠2.0g",
    "通用名": "莫西沙星", "金额": 4383, "集团名称": "拜耳-先灵集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-12月(CPT&CPA) CV IV_20城市_final.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "CV IV data"}'
- data: '{"ATC编码": "C10AA01", "DSCN医院编码": "H14010016", "剂型": "片剂", "包装单位":
    "盒", "医院名称": "山西省心血管疾病医院", "医院编码": 30081, "商品名": "舒降之", "城市": "太原市",
    "季度": 3, "定义市场": "MVT", "年": 2019, "数据来源": "CPA", "数量": 3600, "最小制剂单位数量":
    18000, "最小包装数量": 5, "月": 9, "生产厂家": "杭州默沙东制药有限公司", "省份": "山西省", "级别":
    "三级", "给药途径": "OR", "规格": "40mg", "通用名": "辛伐他汀", "金额": 90612,
    "集团名称": "默沙东集团", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-12月(CPT&CPA) MVT_20城市_final.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "MVT data"}'
- data: '{"ATC编码": "C10AA03", "DSCN医院编码": "H14010016", "剂型": "片剂", "包装单位":
    "盒", "医院名称": "山西省心血管疾病医院", "医院编码": 30081, "商品名": "美百乐镇", "城市": "太原市",
    "季度": 3, "定义市场": "MVT", "年": 2019, "数据来源": "CPA", "数量": 2800, "最小制剂单位数量":
    19600, "最小包装数量": 7, "月": 9, "生产厂家": "第一三共制药(上海)有限公司", "省份": "山西省",
    "级别": "三级", "给药途径": "OR", "规格": "40mg", "通用名": "普伐他汀", "金额":
    166068, "集团名称": "第一三共", "_Tag": "yes"}'
  metadata: '{"fileName": "GYC&CPA/Sankyo/2019年1-12月(CPT&CPA) MVT_20城市_final.xlsx",
    "providers": ["Sankyo", "GYC&CPA"], "sheetName": "MVT data"}'
